Partner Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Partner Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$451K	Sell	5,329 -24,012	-82%	-$1.81M	3.24%	13
2019 Q3	$1.98M	Buy	29,341 +3,731	+15%	+$287K	3.39%	6
2019 Q2	$2.19M	Buy	+25,610	New	+$2.19M	2.33%	9
2017 Q3	–	Sell	-3,973	Closed	-$361K	–	88
2017 Q2	$361K	Sell	3,973 -17,991	-82%	-$1.64M	0.49%	58
2017 Q1	$1.93M	Sell	21,964 -2,510	-10%	-$223K	2.35%	9
2016 Q4	$2.03M	Buy	24,474 +8,839	+57%	+$760K	2.69%	7
2016 Q3	$1.45M	Buy	15,635 +3,883	+33%	+$366K	2.15%	12
2016 Q2	$914K	Buy	+11,752	New	+$999K	1.5%	28

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Partner Investment Management's BMRN Position: Q4 2019 in Review

Partner Investment Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 82% in Q4 2019, selling an estimated $1.81M and leaving 5,329 shares worth $451K. The position accounts for 3.24% of the portfolio, ranked #13.

Partner Investment Management first reported a position in BMRN in Q2 2016 and has held it in 8 quarters since. The position peaked at $2.19M in Q2 2019. 468 funds tracked by Wall St. Rank hold BMRN as of Q4 2019.

Partner Investment Management held 5,329 shares of BioMarin Pharmaceuticals worth $451K as of Q4 2019.
Partner Investment Management sold 24,012 BioMarin Pharmaceuticals shares in Q4 2019, an estimated $1.81M.
BioMarin Pharmaceuticals made up 3.24% of Partner Investment Management's portfolio in Q4 2019, its #13 holding.
Partner Investment Management first reported a position in BioMarin Pharmaceuticals in Q2 2016 and has held it in 8 quarters since.
Partner Investment Management's BioMarin Pharmaceuticals position peaked at $2.19M in Q2 2019.
468 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.